Founded in 2014, Cytecare Hospitals operates in the Health Tech sector offering patient-centric healthcare services in Bangalore, India, with a focus on oncology. It provides global healthcare standar...
Funding stage:
Series A
Last funding:
30/05/2018
Total funding:
$31.00 Mn+
Revenue:
Investors
Employee count:
564
Last 90d
564
Last 90d
Web traffic:
19.89K
19.89K
Last 30d
Last 30d
Glassdoor Rating:
Cytecare Hospitals: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders35
Latest Filing Date30 March 2024- Funding Events44
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Cytecare Hospitals
As of 31 March 2024, Cytecare Hospitals's equity is held by 33 shareholders, with the top three being Broad Street Investments Holding Pte Ltd, Antelope Summit Investment Limited, and Jacesa Investment Limited.
Broad Street Investments Holding Pte Ltd holds the largest stake in Cytecare Hospitals at 14.8% as of 31 March 2024.
As of 31 March 2024, founders collectively hold 5.9% equity in Cytecare Hospitals.
As of 31 March 2024, investors collectively hold 63.6% equity in Cytecare Hospitals.
Cytecare Hospitals's ESOP pool stands at 16.3% of total equity as of 31 March 2024.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links